02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.45
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.99x
- Price / sales
- 1.75x
- Price / cash flow
- 20.51x
Enterprise value
- Enterprise value
- HKD 2.1B
- EV / sales
- 1.99x
- EV / EBITDA
- -279.40x
- EV / EBIT
- -15.58x
- Market cap
- HKD 1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025